دورية أكاديمية

Dual-Vaping of Nicotine and Cannabis Among Adults Who Currently Use Tobacco Products in Five New England States.

التفاصيل البيبلوغرافية
العنوان: Dual-Vaping of Nicotine and Cannabis Among Adults Who Currently Use Tobacco Products in Five New England States.
المؤلفون: Liu J; REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, CA, USA., Hanby E; Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA., Kingsley M; Massachusetts Department of Public Health, Massachusetts Tobacco Cessation and Prevention Program (MTCP), Boston, MA, USA., Winickoff JP; Division of General Academic Pediatrics, Department of Pediatrics, MassGeneral Hospital, Boston, MA, USA.; MGH Tobacco Research and Treatment Center, Boston, MA, USA.; Julius B. Richmond Center, American Academy of Pediatrics, Itasca, IL, USA., Gundersen DA; Rutgers Institute for Nicotine and Tobacco Studies, New Brunswick, NJ, USA.; Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Tan ASL; Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Tobacco and Environmental Carcinogenesis Program, Philadelphia, PA, USA.
المصدر: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco [Nicotine Tob Res] 2024 Aug 22; Vol. 26 (9), pp. 1253-1258.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815751 Publication Model: Print Cited Medium: Internet ISSN: 1469-994X (Electronic) Linking ISSN: 14622203 NLM ISO Abbreviation: Nicotine Tob Res Subsets: MEDLINE
أسماء مطبوعة: Publication: <2009->: Oxford : Oxford University Press
Original Publication: Abingdon, Oxfordshire, UK : Carfax Pub. and Society for Research on Nicotine and Tobacco, c1999-
مواضيع طبية MeSH: Vaping*/epidemiology , Vaping*/psychology, Humans ; Adult ; Male ; Female ; New England/epidemiology ; Middle Aged ; Young Adult ; Nicotine/administration & dosage ; Cross-Sectional Studies ; Tobacco Products/statistics & numerical data ; Surveys and Questionnaires ; Adolescent ; Cannabis ; Cannabidiol/administration & dosage
مستخلص: Introduction: Current measures of vaping behaviors in the U.S. do not distinguish what substances participants are vaping and to what extent they are dual-vaping nicotine and cannabis. This study describes the use of new survey questions that more specifically ask whether participants who vape are vaping nicotine, cannabis, cannabidiol (CBD), or another substance.
Aims and Methods: Adults, who reported any past 30-day tobacco use, from five New England states participated in an online survey from April 2021 to July 2022. Participants who vaped were asked, "Have you used any of the following vape substances in the past 30 days?" with the possible responses of nicotine, cannabis, CBD, other, and "don't know." Dual use of both nicotine and cannabis was defined as the vaping of both nicotine and cannabis and/or CBD in the past 30 days, operationalized as a dichotomous outcome. Data were collected in monthly, repeated cross-sectional waves. Multinomial logistic regression was used to examine correlates of dual-vaping.
Results: The analytic sample included 1547 adults who reported past 30-day tobacco use (mean age 42.9 years, 62.8% female, 85.4% White, 48.5% income of less than $50 000). Over one-quarter (26.1%) reported dual-vaping in the past 30 days. Identifying as male (p = .002) and self-rated anxiety (p = .043) were associated with a higher odds of dual-vaping.
Conclusions: Our findings show that a sizable proportion of a sample of New England adults who have used tobacco in the past 30 days are dual-vaping nicotine and cannabis. Adequate survey measures for assessing the vaping of multiple substances can help in better screening and characterization of health behaviors around dual-use.
Implications: This study addresses a key gap in adequate survey measures for assessing vaping of multiple substances. We found that among adults with past 30-day tobacco use, dual-vaping was prevalent and associated with different correlates, such as self-reported anxiety and education level, compared to sole-vaping of nicotine or cannabis. Our findings may help in characterizing and targeting future population-level surveillance and intervention efforts for multiple substance use behaviors.
(© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
References: Addiction. 2021 Jul;116(7):1622-1630. (PMID: 33047862)
Prev Med. 2020 Nov;140:106152. (PMID: 32473268)
BMJ Open. 2021 Sep 1;11(9):e045445. (PMID: 34470790)
Addict Behav Rep. 2022 Oct 26;16:100465. (PMID: 36341309)
Addict Behav. 2015 Oct;49:26-32. (PMID: 26036666)
Soc Sci Med. 2010 Jul;71(2):251-258. (PMID: 20488602)
Drug Alcohol Depend. 2020 Dec 1;217:108254. (PMID: 32979736)
Subst Abus. 2021;42(3):339-347. (PMID: 31951806)
Prev Med. 2020 Oct;139:106175. (PMID: 32593733)
Nicotine Tob Res. 2018 Feb 7;20(3):362-369. (PMID: 28064202)
Nicotine Tob Res. 2020 Apr 21;22(5):597-598. (PMID: 31956918)
Ann Intern Med. 2007 Mar 6;146(5):317-25. (PMID: 17339617)
Addict Behav. 2019 Mar;90:354-361. (PMID: 30522075)
Addict Behav. 2020 Jan;100:106109. (PMID: 31522133)
Med Care. 2003 Nov;41(11):1284-92. (PMID: 14583691)
J Sch Health. 2022 Jul;92(7):720-727. (PMID: 35304758)
Nicotine Tob Res. 2021 May 4;23(5):829-835. (PMID: 33196838)
Addict Behav. 2023 Nov;146:107804. (PMID: 37478525)
Ann Thorac Surg. 2016 May;101(5):1644-5. (PMID: 27106412)
Addiction. 2022 Aug;117(8):2316-2324. (PMID: 35588004)
Addict Behav. 2018 Feb;77:21-27. (PMID: 28941933)
BMJ Open. 2019 Jun 13;9(6):e028535. (PMID: 31196904)
معلومات مُعتمدة: R21 DA052421 United States DA NIDA NIH HHS; United States CA NCI NIH HHS; 2T32CA057711-27 United States NH NIH HHS
المشرفين على المادة: 6M3C89ZY6R (Nicotine)
19GBJ60SN5 (Cannabidiol)
تواريخ الأحداث: Date Created: 20240319 Date Completed: 20240822 Latest Revision: 20240824
رمز التحديث: 20240826
مُعرف محوري في PubMed: PMC11339159
DOI: 10.1093/ntr/ntae062
PMID: 38502116
قاعدة البيانات: MEDLINE
الوصف
تدمد:1469-994X
DOI:10.1093/ntr/ntae062